Keros Therapeutics, Inc. 8-K

What Happened
Keros Therapeutics, Inc. (KROS) filed a Form 8-K on June 1, 2026, disclosing that President and Chief Executive Officer Jasbir Seehra will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. Eastern time. The company issued a press release dated June 1, 2026 (furnished as Exhibit 99.1) announcing the event.

Key Details

• Item 7.01 (Regulation FD Disclosure): CEO Jasbir Seehra will speak in a fireside chat on June 8, 2026 at 4:00 p.m. ET.
• Press release dated June 1, 2026 was furnished as Exhibit 99.1 to the Form 8-K.
• The disclosure is furnished under Regulation FD and expressly stated as “furnished” (not “filed”) for purposes of Section 18 of the Exchange Act.

Why It Matters
This is a corporate communications event that provides investors an opportunity to hear directly from Keros’ CEO about the company’s strategy, progress, or pipeline updates at a major healthcare investor conference. Because the release is furnished under Regulation FD, it signals controlled public disclosure rather than a regulatory filing of substantive new financial results; investors should look for any additional filings or presentations for material updates.